Patents by Inventor Craig Andrew Erickson

Craig Andrew Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210251997
    Abstract: Disclosed are methods of treating a symptom selected from irritability, self-injurious behavior, intermittent explosive disorder, disruptive behavior disorder, and/Of aggression in an individual diagnosed with a Neurodevelopmental Disorder (NDD) such as autism spectrum disorder (ASD). The methods comprise the step of administering to an individual in need thereof a formulation comprising paliperidone.
    Type: Application
    Filed: February 22, 2021
    Publication date: August 19, 2021
    Inventors: Craig Andrew Erickson, Ernest Vijay Pedapati, Logan Wink
  • Publication number: 20190321367
    Abstract: Disclosed are methods of treating a symptom selected from irritability, self-injurious behavior, intermittent explosive disorder, disruptive behavior disorder, and/or aggression in an individual diagnosed with a Neurodevelopmental Disorder (NDD) such as autism spectrum disorder (ASD). The methods comprise the step of administering to an individual in need thereof a formulation comprising paliperidone.
    Type: Application
    Filed: November 21, 2017
    Publication date: October 24, 2019
    Inventors: Craig Andrew Erickson, Ernest Vijay Pedapati, Logan Wink
  • Publication number: 20170095429
    Abstract: Disclosed are compositions and methods for the treatment of a subject having an autism spectrum disorder. The disclosed compositions may contain racemic ketamine or S-ketamine. The disclosed methods of administering the compositions include intranasal administration to a subject having an autism spectrum disorder.
    Type: Application
    Filed: October 27, 2016
    Publication date: April 6, 2017
    Inventors: Craig Andrew Erickson, Logan Kristen Wink, Tori Lynn Schaefer
  • Patent number: 9610259
    Abstract: Disclosed are compositions and methods for the treatment of a subject having an autism spectrum disorder. The disclosed compositions may contain racemic ketamine or S-ketamine. The disclosed methods of administering the compositions include intranasal administration to a subject having an autism spectrum disorder.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: April 4, 2017
    Assignee: Children's Hospital Medical Center
    Inventors: Craig Andrew Erickson, Logan Kristen Wink, Tori Lynn Schaefer
  • Publication number: 20150196501
    Abstract: Disclosed are compositions and methods for the treatment of a subject having an autism spectrum disorder. The disclosed compositions may contain racemic ketamine or S-ketamine. The disclosed methods of administering the compositions include intranasal administration to a subject having an autism spectrum disorder.
    Type: Application
    Filed: January 14, 2015
    Publication date: July 16, 2015
    Inventors: Craig Andrew Erickson, Logan Kristen Wink, Tori Lynn Schaefer